Antoni Riera‐Mestre

ORCID: 0000-0001-9411-804X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Anomalies and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Central Venous Catheters and Hemodialysis
  • Tracheal and airway disorders
  • COVID-19 Clinical Research Studies
  • Vascular Malformations and Hemangiomas
  • Diagnosis and Treatment of Venous Diseases
  • Sharing Economy and Platforms
  • Acute Ischemic Stroke Management
  • Acute Myocardial Infarction Research
  • Vascular anomalies and interventions
  • Pulmonary Hypertension Research and Treatments
  • Sepsis Diagnosis and Treatment
  • Long-Term Effects of COVID-19
  • Family and Patient Care in Intensive Care Units
  • Blood Coagulation and Thrombosis Mechanisms
  • Cardiovascular Effects of Exercise
  • Diet and metabolism studies
  • Intensive Care Unit Cognitive Disorders
  • Cardiac tumors and thrombi
  • Pharmacological Effects and Toxicity Studies
  • Herpesvirus Infections and Treatments
  • Ocular Diseases and Behçet’s Syndrome
  • Respiratory viral infections research

Institut d'Investigació Biomédica de Bellvitge
2015-2025

Universitat de Barcelona
2016-2025

Bellvitge University Hospital
2016-2025

Instituto de Salud Carlos III
2024-2025

Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition
2024

Ajuntament de L’Hospitalet
2022

Technical University of Munich
2019

Sociedad Española de Medicina Interna
2018

Universitat Internacional de Catalunya
2014-2016

Hospital Terrassa
2006

The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain.To determine whether rivaroxaban is noninferior to dose-adjusted vitamin K antagonists (VKAs) for thrombotic APS.3-year, open-label, randomized noninferiority trial. (EU Clinical Trials Register: EUDRA [European Union Drug Regulatory Authorities] code 2010-019764-36).6 university hospitals Spain.190 adults (aged 18 75 years) with APS.Rivaroxaban (20 mg/d or 15 mg/d, according renal...

10.7326/m19-0291 article EN Annals of Internal Medicine 2019-10-14

Introduction Loss-of-function TLR7 variants have been recently reported in a small number of males to underlie strong predisposition severe COVID-19. We aimed determine the presence these rare young men with Methods prospectively studied between 18 and 50 years-old without predisposing comorbidities that required at least high-flow nasal oxygen treat The coding region was sequenced assess potentially deleterious variants. Results missense were identified two out 14 patients (14.3%). Overall,...

10.3389/fimmu.2021.719115 article EN cc-by Frontiers in Immunology 2021-07-23

It is important to predict which patients infected by SARS-CoV-2 are at higher risk of life-threatening COVID-19. Several studies suggest that neutralizing auto-antibodies (auto-Abs) against type I interferons (IFNs) predictive critical COVID-19 pneumonia.We aimed test for auto-Abs IFN and describe the main characteristics admitted intensive care depending on whether or not these present.Retrospective analysis all an unit (ICU) in whom samples were available, from March 2020 2021, Barcelona,...

10.1007/s10875-021-01136-x article EN other-oa Journal of Clinical Immunology 2021-09-27
Jeffrey I. Weitz Sylvia Haas Walter Ageno Samuel Z. Goldhaber Alexander G.G. Turpie and 95 more Shinya Goto Pantep Angchaisuksiri Jørn Dalsgaard Nielsen Gloria Kayani Alfredo E. Farjat Sebastian Schellong Henri Bounameaux LG Mantovani Paolo Prandoni Ajay K. Kakkar A. Loualidi Abdürrahim Çolak Abraham F. Bezuidenhout A.T.O. Abdool-Carrim Addala Azeddine Adriaan Beyers A Dees Ahmed Mohamed Ahmet Aksoy Akihiko Abiko Akinori Watanabe Alan Krichell Alberto Alfredo Fernandez Alberto Tosetto Alexey Khotuntsov Alisha Oropallo Alison Slocombe Allan Kelly Amanda Clark Amr Gad Amy Arouni Andor Schmidt Andrea Berni Andres Javier Kleiban A Machowski Andrey Kazakov Ángel Gálvez Ann Lockman Anna Falanga Anoop Chauhan Antoni Riera‐Mestre Antonino Mazzone Armando D’Angelo Artur Haddad Herdy Atsushi Kato Ayman Abd Elhamid Ebrahim Mahmoud Salem Azlan Husin Barbara Erdelyi Barry Jacobson Beatrice Amann‐Vesti Bektaş Battaloğlu Benedicte Wilson Benilde Cosmi Bergmann Jean Francois Berremeli Toufek Beverley J. Hunt Bhavesh Natha Bisher Mustafa Bonnie Chi Shan Kho Boulon Carine Brian Zidel Brisot Dominique Brousse Christophe Bruno Trimarco Canhua Luo Carlos Alberto Cuneo Carlos Jerjes‐Sánchez Carsten Schwencke Cas Cader Celal Yavuz Cesar Javier Zaidman Charles A. Lunn Chau‐Chung Wu Cheng Hock Toh Chern‐En Chiang Chevrier Elisa Chien‐Hsun Hsia Chien-Lung Huang Chi‐Hang Kevin Kwok Chih-Cheng Wu Chi‐Hung Huang Chris Ward Christian Opitz Christina Jeanneret‐Gris Chung Yin Ha Chun‐Yao Huang Claude Luyeye Bidi Clifford Smith Cornelia Brauer Corrado Lodigiani Françis Couturaud Cynthia Wu Daniel Staub Daniel Theodoro Daniela Poli

10.1007/s11239-020-02180-x article EN Journal of Thrombosis and Thrombolysis 2020-06-24

Summary The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a limited extent by bodyweight; therefore, dose adjustments for bodyweight not required. However, this raises concerns among physicians potential under- or overdosing. This substudy the randomised EINSTEIN DVT PE trials, which compared with enoxaparin/vitamin K antagonist (VKA) therapy, aimed determine incidence major bleeding in patients low recurrent venous thromboembolism (VTE) high during...

10.1160/th16-02-0087 article EN Thrombosis and Haemostasis 2016-01-01

Metabolic syndrome (MetS) is associated with alterations of lipoprotein structure and function that can be characterized advanced testing (ADLT). The effect the Mediterranean diet (MedDiet) weight loss on subclass profile has been scarcely studied. Within PREDIMED-Plus randomized controlled trial, a sub-study conducted at Bellvitge Hospital recruiting center evaluated effects program based an energy-reduced MedDiet (er-MedDiet) physical activity (PA) promotion (intervention group) compared...

10.3390/ijms25021338 article EN International Journal of Molecular Sciences 2024-01-22

Hemorrhagic hereditary telangiectasia (HHT) type 2 patients have increased activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway in telangiectasia. The main objective is to evaluate PI3K cutaneous HHT1 patients. A biopsy a digital hand was performed seven and eight HHT2 compared with six controls. study approved by Clinical Research Ethics Committee our center. histopathological pattern more dilated superficial vessels that pushed up epidermis identified HHT regardless...

10.3390/cells8090971 article EN cc-by Cells 2019-08-24
Sylvia Haas Walter Ageno Jeffrey I. Weitz Samuel Z. Goldhaber Alexander G.G. Turpie and 95 more Shinya Goto Pantep Angchaisuksiri Joern Dalsgaard Nielsen Gloria Kayani Audrey Zaghdoun Alfredo E. Farjat Sebastian Schellong Henri Bounameaux LG Mantovani Paolo Prandoni Ajay K. Kakkar A. Loualidi Abdürrahim Çolak Abraham F. Bezuidenhout A.T.O. Abdool-Carrim Addala Azeddine Adriaan Beyers A Dees Ahmed Mohamed Ahmet Aksoy Akihiko Abiko Akinori Watanabe Alan Krichell Alberto Alfredo Fernandez Alberto Tosetto Alexey Khotuntsov Alisha Oropallo Alison Slocombe Allan Kelly Amanda Clark Amr Gad Amy Arouni Andor Schmidt Andrea Berni Andres Javier Kleiban A Machowski Andrey Kazakov Ángel Gálvez Ann Lockman Anna Falanga Anoop Chauhan Antoni Riera‐Mestre Antonino Mazzone Armando D’Angelo Artur Haddad Herdy Atsushi Kato Ayman Abd Elhamid Ebrahim Mahmoud Salem Azlan Husin Barbara Erdelyi Barry Jacobson Beatrice Amann‐Vesti Bektaş Battaloğlu Benedicte Wilson Benilde Cosmi Bergmann Jean Francois Berremeli Toufek Beverley Hunt Bhavesh Natha Bisher Mustafa Bonnie Chi Shan Kho Boulon Carine Brian Zidel Brisot Dominique Brousse Christophe Bruno Trimarco Canhua Luo Carlos Alberto Cuneo Carlos Jerjes‐Sánchez Carsten Schwencke Cas Cader Celal Yavuz Cesar Javier Zaidman Charles A. Lunn Chau‐Chung Wu Cheng Hock Toh Chern‐En Chiang Chevrier Elisa Chien‐Hsun Hsia Chien‐Lung Huang Chi‐Hang Kevin Kwok Chih‐Cheng Wu Chi‐Hung Huang Chris Ward Christian Opitz Christina Jeanneret‐Gris Chung Yin Ha Chun‐Yao Huang Claude Luyeye Bidi Clifford Smith Cornelia Brauer Corrado Lodigiani Françis Couturaud Cynthia Wu Daniel Staub

10.1111/jth.14548 article EN publisher-specific-oa Journal of Thrombosis and Haemostasis 2019-06-20

SARS-CoV-2 vaccines' effectiveness is not yet clearly known in immunocompromised patients. This study aims to assess the humoral and cellular specific immune response vaccines predictors of poor patients with common variable immunodeficiency (CVID) phenotype treated B-cell depletion therapies (BCDT), as well safety these vaccines. From March September 2021, we performed a prospective all adult who would receive vaccination were previously diagnosed (i) CVID syndrome (CVID group; n=28) or...

10.3389/fimmu.2022.895209 article EN cc-by Frontiers in Immunology 2022-04-29

Distinct endothelial cell cycle states (early G1 versus late G1) provide different "windows of opportunity" to enable the differential expression genes that regulate venous arterial specification, respectively. Endothelial control and arteriovenous identities are disrupted in vascular malformations including shunts, hallmark hereditary hemorrhagic telangiectasia (HHT). To date, mechanistic link between regulation development (AVMs) HHT is not known.

10.1161/circulationaha.122.062952 article EN Circulation 2023-12-21

Rationale: Patients with acute symptomatic pulmonary embolism (PE) deemed to be at low risk for early complications might candidates partial or complete outpatient treatment.Objectives: To develop and validate a clinical prediction rule that accurately identifies patients PE of short-term compare its prognostic ability two previously validated models (i.e., the Pulmonary Embolism Severity Index [PESI] Simplified PESI [sPESI])Methods: Multivariable logistic regression large international...

10.1513/annalsats.201504-202oc article EN Annals of the American Thoracic Society 2015-06-26

Abstract Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease with autosomal dominant inheritance. Disease-causing variants in endoglin ( ENG ) and activin A receptor type II-like 1 ACVRL1 genes are detected more than 90% of cases submitted to molecular diagnosis. Methods We used data from the RiHHTa (Computerized Registry Hemorrhagic Telangiectasia) registry describe genetic assess their genotype-phenotype correlation among HHT patients Spain. Results By May...

10.1186/s13023-020-01422-8 article EN cc-by Orphanet Journal of Rare Diseases 2020-06-05
Alexander G.G. Turpie Alfredo E. Farjat Sylvia Haas Walter Ageno Jeffrey I. Weitz and 95 more Samuel Z. Goldhaber Shinya Goto Pantep Angchaisuksiri Gloria Kayani Renato D. Lópes Chern‐En Chiang Harry Gibbs Eric Tse Peter Verhamme Hugo Ten Cate Juan Muntaner Sebastian Schellong Henri Bounameaux Paolo Prandoni Uma Maheshwari Ajay K. Kakkar A. Loualidi Abdürrahim Çolak Abraham F. Bezuidenhout A.T.O. Abdool-Carrim Addala Azeddine Adriaan Beyers A Dees Ahmed Mohamed Ahmet Aksoy Akihiko Abiko Akinori Watanabe Alan Krichell Alberto Alfredo Fernandez Alberto Tosetto Alexey Khotuntsov Alisha Oropallo Alison Slocombe Allan Kelly Amanda Clark Amr Gad Amy Arouni Andor Schmidt Andrea Berni Andres Javier Kleiban A Machowski Andrey Kazakov Ángel Gálvez Ann Lockman Anna Falanga Anoop Chauhan Antoni Riera‐Mestre Antonino Mazzone Armando D’Angelo Artur Haddad Herdy Atsushi Kato Ayman Abd Elhamid Ebrahim Mahmoud Salem Azlan Husin Barbara Erdelyi Barry Jacobson Beatrice Amann‐Vesti Bektaş Battaloğlu Benedicte Wilson Benilde Cosmi Bergmann Jean Francois Berremeli Toufek Beverley Hunt Bhavesh Natha Bisher Mustafa Bonnie Chi Shan Kho Boulon Carine Brian Zidel Brisot Dominique Brousse Christophe Bruno Trimarco Canhua Luo Carlos Alberto Cuneo Carlos Jerjes‐Sánchez Carsten Schwencke Cas Cader Celal Yavuz Cesar Javier Zaidman Charles A. Lunn Chau‐Chung Wu Cheng Hock Toh Chern‐En Chiang Chevrier Elisa Chien‐Hsun Hsia Chien-Lung Huang Chi‐Hang Kevin Kwok Chih-Cheng Wu Chi‐Hung Huang Chris Ward Christian Opitz Christina Jeanneret‐Gris Chung Yin Ha Chun‐Yao Huang Claude Luyeye Bidi Clifford Smith Cornelia Brauer

Venous thromboembolism (VTE), encompassing both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a leading cause of morbidity mortality worldwide.GARFIELD-VTE prospective, non-interventional observational study real-world treatment practices. We aimed to capture the 36-month clinical outcomes 10,679 patients with objectively confirmed VTE enrolled between May 2014 January 2017 from 415 sites in 28 countries.A total 6582 (61.6 %) had DVT alone, 4097 (38.4 PE ± DVT. At baseline, 98.1...

10.1016/j.thromres.2022.11.016 article EN cc-by Thrombosis Research 2022-11-25
Lisa Baumann Kreuziger Lauren Cote Peter Verhamme Steven B. Greenberg Joseph A. Caprini and 95 more Francisco J. Muñoz Reina Valle Manuel Monreal Bosch Manuel Monréal Hervé Decousus Paolo Prandoni Benjamin Brenner Raquel Barba Pierpaolo Di Micco Laurent Bertoletti Sebastian Schellong Inna Tzoran Abílio Reis Marijan Bosevski Henri Bounameaux Radován Malý Philip Wells M. Alcalde A. Alibalic Juan I. Arcelus Teresa Auguet Raquel Barba M. Barrón B. Barrón‐Andrés J. Bascuñana Juan Benitez Á. Blanco-Molina I. Casado Francisco Conget Fátima del Molino J. del Toro José A. Díaz C. Falgá Carmen Fernández‐Capitán Llorenç Font P. Gallego F. García‐Bragado Antonio Torres García M Gomez-Duran Vicente Gómez del Olmo J. González E Grau Ricardo Guijarro Juan Mata Luís Hernández S. Hernández-Huerta Luis Jara‐Palomares M.J. Jaras David Jiménez Ruth Jiménez Castuera Sergio A. Jiménez Ramón Lecumberri J.L. Lobo Luciano López‐Jiménez L. López‐Montes Raquel López-Reyes J.B. López‐Sáez M.A. Lorente A. García de Lorenzo M. Macià Olga Madridano Pablo Javier Marchena J.M. Martín‐Antorán F. Martín‐Martos M. Monreal M.V. Morales F.J. Muñoz D. Nauffal José Antonio Nieto Manuel Jesús Núñez Remedios Otero B. Pagán José María Pedrajas Gloria Pérez‐Rus M.L. Peris I. Pons José Antonio Porras Antoni Riera‐Mestre A. Rivas M.A. Rodríguez‐Dávila P. Román V. Rosa N. Ruiz‐Giménez P. Sabio A. Sampériz Rosario Sánchez‐Martínez O. Sanz S. Soler B. Sopeña M.J. Soto José María Suriñach G Tiberio Raimundo Tirado J. Trujillo-Santos Fernando Uresandi

10.1016/j.jvsv.2015.03.002 article EN Journal of Vascular Surgery Venous and Lymphatic Disorders 2015-06-15

We aimed to describe risk factors for gastrointestinal (GI) bleeding and endoscopic findings in patients with hereditary hemorrhagic telangiectasia (HHT).This is a prospective study from referral HHT unit. Endoscopic tests were performed when there was suspicion of GI bleeding, divided as follows: with, without, unsuspected involvement.67 (27.9%) 28 (11.7%) 145 (60.4%) involvement included. Age, tobacco use, endoglin (ENG) mutation, hemoglobin associated involvement. Telangiectases mostly...

10.3390/jcm9010082 article EN Journal of Clinical Medicine 2019-12-28

Abstract Background Gender differences in organ involvement and clinical severity have been poorly described hereditary hemorrhagic telangiectasia (HHT). The aim of this study was to describe the HHT manifestations according gender. Methods Severity measured Epistaxis Score (ESS), Simple Clinical Scoring Index for hepatic involvement, a general HHT-score, needing invasive treatment (pulmonary or brain arteriovenous malformations -AVMs- embolization, liver transplantation Young’s surgery)...

10.1186/s13023-020-1337-5 article EN cc-by Orphanet Journal of Rare Diseases 2020-03-02
Carmen Fernández‐Capitán Ana Rodríguez Cobo David Jiménez Olga Madridano Maurizio Ciammaichella and 95 more Esther Usandizaga Remedios Otero Pierpaolo Di Micco Farès Moustafa Manuel Monréal María Dolores Adarraga Miguel Ángel Aibar Arregui M. Alfonsa Juan I. Arcelus Pedro María Azcárate-Agüero Aitor Ballaz Pedro A. Parra Baños Raquel Barba M. Barrón B. Barrón‐Andrés J. Bascuñana Á. Blanco-Molina A.M. Camón Leyre Chasco A.J. Cruz Roberto del Pozo Javier de Miguel‐Díez J. del Toro Carmen Díaz‐Pedroche J.A. Díaz‐Peromingo J.C. Escribano C. Falgá C. Fernández‐Aracil M.A. Fidalgo Carme Font Llorenç Font Marian García-Núñez F. García‐Bragado Marcial García-Morillo Aránzazu García‐Raso Aldara García‐Sánchez O. Gavín Ignacio Gayá García‐Manso Cristina Gómez Vicente Gómez del Olmo J. González E Grau Ricardo Guijarro Javier Gutiérrez G. Hernández-Comes Luis Blasco E. Rocha Hernando Luis Jara‐Palomares M.J. Jaras David Jiménez M.D. Joya J. Lima Pilar Llamas J.L. Lobo Raquel López-Reyes J.B. López‐Sáez M.A. Lorente A. Lorenzo M. Lumbierres Ana Maestre Pablo Javier Marchena F. Martín‐Martos Mercedes Martı́n-Romero M.V. Morales José Antonio Nieto Santiago Nieto Antonio Rodríguez‐Núñez Manuel Jesús Núñez M. Odriozola M.C. Olivares S. Otálora José María Pedrajas G. Pellejero C. Pérez‐Ductor M.L. Peris I. Pons José Antonio Porras L. Ramírez Òscar Reig Antoni Riera‐Mestre David Riesco A. Rivas M.A. Rodríguez‐Dávila V. Rosa Pedro Ruiz‐Artacho Joan Carles Sahuquillo M.C. Sala‐Sainz A. Sampériz R. Sánchez‐Martínez S. Soler B. Sopeña José María Suriñach Carlos Tolosa Marı́a Isabel Torres José M. Troya

The optimal therapy of patients with acute subsegmental pulmonary embolism (PE) is controversial.

10.1002/rth2.12446 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2020-11-19
Coming Soon ...